ÂÜÀòÂÒÂ×

Dr. Hayward is the co-founder, President, and Chief Executive Officer at eXIthera Pharmaceuticals, Inc. Dr. Hayward previously served as the Vice President of Pharmacology & Toxicology at Hydra Biosciences, a role in which he identified and selected potential therapeutic targets, executed preclinical studies, and subsequently nominated small molecules as development candidates for internal projects and external collaborations (Cubist Pharmaceuticals, Pfizer and Zalicus). Dr. Hayward has also held positions of increasing responsibility in both pharmaceutical (GSK and Pfizer) and biotechnology companies (Alkermes, Praecis, and Daiamed). He has over 30 years of experience in discovery and preclinical research and development. Dr. Hayward has successfully filed seven INDs. He holds his B.Sc. from the University of London and his M.Phil. and Ph.D. in Pharmacology from the University of Cambridge, UK.